Oral mucositis in head and neck cancer: Evidence-based management and review of clinical trial data

A Blakaj, M Bonomi, ME Gamez, DM Blakaj - Oral oncology, 2019 - Elsevier
Oral Mucositis (OM) continues to be an oncologic challenge in the context of antineoplastic
therapy for head and neck cancer (HNC) treatment. It is a dose-limiting toxicity of …
被引用次数：96 相关文章

[引用][C] Oral mucositis in head and neck cancer: Evidence-based management and review of clinical trial data

A Blakaj, M Bonomi, ME Gamez, DM Blakaj - Oral Oncology, 2019 - hero.epa.gov
Oral mucositis in head and neck cancer: Evidence-based management and review of
clinical trial data | Health & Environmental Research Online (HERO) | US EPA Jump to main …

Oral mucositis in head and neck cancer: Evidence-based management and review of clinical trial data

A Blakaj, M Bonomi, ME Gamez, DM Blakaj - Oral Oncology, 2019 - Elsevier
Oral Mucositis (OM) continues to be an oncologic challenge in the context of antineoplastic
therapy for head and neck cancer (HNC) treatment. It is a dose-limiting toxicity of …

[引用][C] Oral mucositis in head and neck cancer: Evidence-based management and review of clinical trial data

A Blakaj, M Bonomi, ME Gamez, DM Blakaj - Oral Oncology, 2019 - cir.nii.ac.jp
Oral mucositis in head and neck cancer: Evidence-based management and review of clinical
trial data | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …

Oral mucositis in head and neck cancer: Evidence-based management and review of clinical trial data

A Blakaj, M Bonomi, ME Gamez… - Oral …, 2019 - pubmed.ncbi.nlm.nih.gov
Oral Mucositis (OM) continues to be an oncologic challenge in the context of antineoplastic
therapy for head and neck cancer (HNC) treatment. It is a dose-limiting toxicity of …

Oral mucositis in head and neck cancer: Evidence-based management and review of clinical trial data

A Blakaj, M Bonomi, ME Gamez… - Oral …, 2019 - ohiostate.elsevierpure.com
Oral Mucositis (OM) continues to be an oncologic challenge in the context of antineoplastic
therapy for head and neck cancer (HNC) treatment. It is a dose-limiting toxicity of …

Oral mucositis in head and neck cancer: Evidence-based management and review of clinical trial data.

A Blakaj, M Bonomi, ME Gamez, DM Blakaj - Oral Oncology, 2019 - europepmc.org
Oral Mucositis (OM) continues to be an oncologic challenge in the context of antineoplastic
therapy for head and neck cancer (HNC) treatment. It is a dose-limiting toxicity of …